Search / Trial NCT06234410

Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation

Launched by UNIVERSITY OF EDINBURGH · Jan 22, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

Coronary Artery Disease Kidney Transplantation Cardiovascular Risk Assessment Heart Disease Chronic Kidney Disease

ClinConnect Summary

This clinical trial is studying how a special heart scan called computed tomography coronary angiography (CTCA) can help identify patients who are at high risk for heart problems before they receive a kidney transplant. Research has shown that even though kidney transplants can lower the risk of heart disease, many patients still face serious heart-related issues after the transplant. The goal of this study is to see if CTCA can better pinpoint which patients need extra care before undergoing a kidney transplant.

To participate in this trial, you need to be 16 years or older, have kidney failure, and be on the waitlist for a kidney transplant. You should also be able to give informed consent, meaning you understand the study and agree to participate. If you have any allergies to the contrast dye used in the CT scan or if you're being considered for certain types of combined organ transplants, you may not be eligible. If you join the study, you can expect to undergo the CTCA scan, which will help doctors assess your cardiovascular risk more accurately.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Has kidney failure and is on the waitlist for a kidney transplant
  • Age 16 years and over
  • Able to give informed consent
  • Exclusion Criteria:
  • Contraindication to CT scanning, including contrast allergy
  • Patients being considered for a simultaneous kidney-pancreas, kidney-liver and/or kidney-islet transplantation
  • Inability to give informed consent

Trial Officials

Neeraj Dhaun, MBChB

Principal Investigator

University of Edinburgh

About University Of Edinburgh

The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.

Locations

Edinburgh, Lothian, United Kingdom

Glasgow, , United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0